©The Author(s) 2025.
World J Diabetes. Oct 15, 2025; 16(10): 109568
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.109568
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.109568
Figure 8 Kunkui Baoshen decoction alleviates fibrosis by inhibiting ferroptosis in vitro and in vivo.
A-C: Levels of Fe2+/Fe3+, malondialdehyde, and glutathione/oxidized glutathione in renal tissues; D: Reactive oxygen species levels assessed by fluorescence microscopy in renal tissues (scale bars = 50 μm); E: Transmission electron microscopy images showing mitochondrial morphological changes related to ferroptosis in renal tissues (scale bars = 2 μm). L-KKBS: Low-dose Kunkui Baoshen decoction; H-KKBS: High-dose Kunkui Baoshen decoction; MDA: Malondialdehyde; GSH: Glutathione; GSSG: Oxidized glutathione; ROS: Reactive oxygen species. bP < 0.01 vs db/m group, dP < 0.0001 vs db/m group, eP < 0.05 vs db/db group, fP < 0.01 vs db/db group, and hP < 0.0001 vs db/db group.
- Citation: Song SY, Shan CC, Zhou PP, Xu WL, Tan Y, Zhou XQ, Huang LJ, Yan QH, Yu JY. Nephroprotective mechanism of Kunkui Baoshen decoction in diabetic kidney disease: Targeting the HERC2/NCOA4-mediated autophagy-dependent ferroptosis pathway. World J Diabetes 2025; 16(10): 109568
- URL: https://www.wjgnet.com/1948-9358/full/v16/i10/109568.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i10.109568